Navigation Links
Study tests reliability of more accurate measure of patient pain
Date:3/9/2009

Amsterdam, The Netherlands March 09, 2009 A new study appearing in Pain Practice successfully established the reliability a newly developed device for assessing pain. This device is called the continuous pain score meter (CPSM). It enables continuous real time pain score measurement, which is used to obtain exact measurements of pain intensity in humans during the course of a procedure. The findings provide more detailed information on patients' pain perception and may lead to better pain management for certain clinical procedures.

The ability to accurately measure pain intensity, pain duration and the effect of analgesics is an important task in both medical practice and research. The sharp increase in present-day office procedures, without general anesthesia, has made this even more important. The CPSM procedure can be valuable to study pain intensity in clinical procedures that take between 1-30 minutes.

Currently, there are various validated instruments available to assess pain in patients. The visual analog score (VAS) is the most widely used scale. The VAS scale measures pain by a single score indicated by a patient the end of a procedure. It uses a scale that ranges from "no pain" to "worst imaginable pain." The VAS is frequently used for diagnostic and technical procedures to evaluate patient tolerance in an office setting.

This method, however, has three major disadvantages. If a procedure consists of multiple different actions, pain intensity may vary according to each action. This important information is not detected by a single measurement afterwards. Second, pain intensity measurements after the procedure may be biased by the inaccuracy of the memory to recall pain sensations. Third, pain is by nature not a short, limited phenomenon; pain sensation does not suddenly stop after a stimulus, but gradually disappears, requiring continuous measurements in order to fully cover the pain sensation. With this new pain score meter it is possible to measure pain continuously throughout the procedure. In this way, a clinician gains more insight into the patients' pain perception.

The study used thirty-two healthy volunteers who received a reproducible pain stimulus at one-minute intervals. The stimulus was induced by a dolorimeter, an instrument that applies continuously increasing pressure, on the thumbnail and forearm, as these points are easily accessible and have a low pain threshold. During the stimulus, pain was continuously measured with the CPSM, providing values of peak continuous pain score (peak CPS) and area under the continuous pain score curve (AUC CPS).

"The additional knowledge provided by the CPSM can be very helpful in clinical settings to optimize the use of local analgesia in diagnostic or therapeutic procedures or to adapt the technique into more tolerable procedures," says Dr. Paul van Kesteren, co-author of the study. "Therefore, the CPSM seems to be a better option than conventional techniques for real-time continuous measurement of a subject's pain intensity with adequate reliability."


'/>"/>

Contact: Sean Wagner
medicalnews@bos.blackwellpublishing.net
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. New published study demonstrates over-the-counter device lowers blood pressure in diabetic patients
2. Study prompts new mandate for N.C. high schools
3. UCF study: Hyperactivity enables children with ADHD to stay alert
4. Study Links Internal Source of Aging and Skin Damage
5. Drug combination may be effective against deadly melanoma, pilot study shows
6. New Study Finds Text-Messaging Reminders Effective in Improving Adherence to Sunscreen Use
7. McMaster study sheds light on how stem cells develop into blood cells
8. United Spinal Association Report Reveals the Importance of Studying Multiple Sclerosis in Children: Developing New Insights into MS in Adults
9. Penile extender increased flaccid length by almost a third says independent clinical study
10. UPDATE: NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting
11. Study finds injectable birth control causes significant weight gain and changes in body mass
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: